BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33878446)

  • 1. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
    Sun X; Zhu H; Cao R; Zhang J; Wang X
    Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis.
    Xiao Z; Liu Y; Zhao J; Li L; Hu L; Lu Q; Zeng Z; Liu X; Huang D; Yang W; Xu Q
    Int J Biol Sci; 2020; 16(13):2296-2305. PubMed ID: 32760198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation.
    Li Y; Wu B; Sun R; Zhao M; Li N
    Autoimmunity; 2021 Dec; 54(8):547-560. PubMed ID: 34435526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
    Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
    Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
    Chuang KH; Whitney-Miller CL; Chu CY; Zhou Z; Dokus MK; Schmit S; Barry CT
    Hepatology; 2015 Aug; 62(2):466-80. PubMed ID: 25820676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathway.
    Wang C; Zhang L; Cao M; Fu Z; Wang H; Zhang S; Zhu K; Hou Z; Cui J; Yue P; Guo H; Zhang T
    FASEB J; 2023 Jun; 37(6):e22943. PubMed ID: 37104068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2.
    Xie M; Sun M; Ji X; Li D; Chen X; Zhang B; Huang W; Zhang T; Wang Y; Tian D; Xia L
    Theranostics; 2022; 12(3):1097-1116. PubMed ID: 35154476
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM; Wu QM; Chang LY; Liu JC
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M; Li M; Wang T; Linghu E; Wu B
    Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
    BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
    Zhang PF; Wei CY; Huang XY; Peng R; Yang X; Lu JC; Zhang C; Gao C; Cai JB; Gao PT; Gao DM; Shi GM; Ke AW; Fan J
    Mol Cancer; 2019 Jun; 18(1):105. PubMed ID: 31153371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.